<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-07T14:21:29Z</responseDate>
  <request identifier="oai:figshare.com:article/34000887" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34000887</identifier>
        <datestamp>2026-09-28T01:04:42Z</datestamp>
        <setSpec>category_24490</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Systemic treatments for genital psoriasis in randomised trials: a systematic review and meta-analysis</dc:title>
          <dc:creator>Wen luo (25111791)</dc:creator>
          <dc:creator>Yizheng Li (25111881)</dc:creator>
          <dc:creator>Wanni Li (25111889)</dc:creator>
          <dc:creator>Jiejie Lu (25111884)</dc:creator>
          <dc:creator>Weiwei Wu (25111887)</dc:creator>
          <dc:subject>Dermatology</dc:subject>
          <dc:subject>psoriasis drug development</dc:subject>
          <dc:description>&lt;p dir="ltr"&gt;The deposited files include the outcome inventory, quantitative data extraction sheets, eligibility and analytical decision records, Risk of Bias 2 (RoB 2) assessments, and datasets used for the meta-analysis. Where multiple publications originated from the same clinical trial, they were linked to the corresponding parent trial and treated as a single trial for quantitative synthesis to avoid double counting of participants.&lt;/p&gt;&lt;p dir="ltr"&gt;Extracted outcomes include genital psoriasis clearance or treatment response, genital symptoms and itch, sexual-health outcomes, quality-of-life measures, and safety outcomes, where available. Data are presented at the aggregate study or subgroup level; no individual participant data are included.&lt;/p&gt;&lt;p dir="ltr"&gt;These files are provided to enhance transparency, reproducibility, and independent verification of the systematic review and meta-analysis.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-28T01:04:42Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.6084/m9.figshare.34000887.v2</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Systemic_treatments_for_genital_psoriasis_in_randomised_trials_a_systematic_review_and_meta-analysis/34000887</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
